June 2026
The global critical care drugs market size was evaluated at USD 1.22 billion in 2025 and is projected to surge around USD 2.00 billion by 2035, with a CAGR of 5.07%.
September 2026
The global virtual critical care solutions market size was evaluated at USD 2.66 billion in 2026 and is predicted to hit around USD 9.72 billion by 2035, growing at a CAGR of 15.50%.
September 2026
The critical care devices market size was valued at USD 67.23 billion in 2026 and is projected to hit around USD 95.17 billion by 2033 with a CAGR of 5.09%.
December 2025
The global cancer supportive care drugs market size is projected to hit around USD 27.45 billion by 2035 from USD 22.31 billion in 2025 with a CAGR of 2.09%.
September 2026
The global fixed-dose combination diabetes drugs market gain insights into market dynamics, competitive strategies and future projections for fixed-dose combination therapies designed to meet complex diabetes treatment needs.
September 2026
The asthma and COPD drugs market size reached USD 46.93 billion in 2026, with leading asthma and COPD drugs market companies including AstraZeneca, GlaxoSmithKline (GSK), Novartis.
September 2026
The rheumatoid arthritis drugs market size reached USD 65.51 billion in 2026, with leading rheumatoid arthritis drugs market companies including AbbVie Inc., Sun Pharma, Lupin.
September 2026
The oncology/cancer drugs market size is calculated at USD 214.70 billion in 2026 and is projected to hit around USD 554.69 billion by 2035 with a CAGR of 11.17%.
September 2026
The global 3D printed drugs market size was estimated at USD 400.73 million in 2026 and is predicted to reach around USD 789.20 million by 2034 with a CAGR of 8.84%.
September 2026
The global HIV drugs market size is estimated at USD 40.86 billion in 2026 and is projected to hit around USD 69.88 billion by 2035, growing at a CAGR of 6.15%.
September 2026
The global atrial fibrillation drugs market size was evaluated at USD 16.54 billion in 2026 and is projected to surpass around USD 20.99 billion by 2034, with a CAGR of 3.02%.
September 2026
The U.S. pain management drugs market reached USD 33.84 billion in 2026, with key U.S. pain management drugs companies including abbott, Pfizer, teva pharmaceutical, endo international, depomed, merck.
February 2026
The antihypertensive drugs market size is valued at USD 26.50 billion in 2026 and is expected to be worth around USD 37.29 billion by 2035 with a CAGR of 3.87%.
July 2025
The inhalation and nasal spray generic drugs market size is projected to hit around USD 54.44 billion by 2034 from USD 27.38 billion in 2026, with a CAGR of 8.97%.
August 2025
The global arterial cannula market size was estimated at USD 33.80 million in 2024 and is projected to surpass around USD 54.12 million by 2034, at a CAGR of 4.82%.
August 2025
The global multi-chamber bags for parenteral nutrition market size is estimated to hit around USD 3.21 billion by 2034 increasing from USD 1.55 billion in 2024, with a CAGR of 7.54%.
September 2026
The global PD-1 inhibitor drugs market size was estimated at USD 56.29 billion in 2026 and is expected to hit around USD 201.87 billion by 2035, growing at a CAGR of 15.28% from 2026 to 2035.
September 2026
The healthcare biometrics market size was calculated at USD 11.49 billion in 2026 and is projected to hit around USD 47 billion by 2035 with a CAGR of 16.99%.
September 2026
The advanced wound care market size was valued at USD 18.90 billion in 2026 and is projected to hit around USD 67.31 billion by 2035 with a CAGR of 15.22%
September 2026
The global personal care ingredients market size is valued at USD 16.41 billion in 2026 and is expected to hit around USD 25.96 billion by 2034, growing at a CAGR of 5.92%.
September 2026
The global U.S. oral care market size is calculated at USD 11.11 billion in 2026 and is projected to hit around USD 16.60 billion by 2035 with a CAGR of 4.57%.
September 2026
The global healthcare third-party logistics market size is predicted to surpass around USD 522.87 billion by 2035 from USD 274.56 billion in 2026 with a notable CAGR of 7.44%.
September 2026
The U.S. point of care infectious disease testing market size is projected to hit around USD 5.27 billion by 2035, growing at a CAGR of 8.98% from 2026 to 2035.
September 2026
The healthcare transportation services market size is predicted to surpass around USD 200.20 billion by 2034 from USD 120.55 billion in 2026, with a notable CAGR of 6.56%.
September 2026
The global healthcare laboratory informatics market size is estimated to hit around USD 7.26 billion by 2035 from USD 3.55 billion in 2026 with a CAGR of 8.30%.
September 2026
The global erectile dysfunction drugs market size was estimated at USD 2.93 billion in 2024 and is predicted to be worth around USD 6.74 billion by 2034, with a CAGR of 8.69%.
September 2026
The urgent care center market as worth USD 30.36 billion in 2026, with key urgent care center market layers including Dignity Health, Select Medical Holdings, UnitedHealth Group
September 2026
The virtual care market size was USD 26.55 billion in 2026, with leading virtual care market players including AMD Global Telemedicine American Well, BioTelemetry
September 2026
The global epigenetics drugs and diagnostic technologies market size is estimated to hit around USD 79.03 billion by 2035 increasing from USD 23.13 billion in 2026, with a CAGR of 14.63%.
September 2026
The global cognitive assessment and training in healthcare market size was evaluated at USD 7.31 billion in 2026 and is predicted to hit around USD 36.90 billion by 2035, growing at a CAGR of 19.70%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com